Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Country / region: Italy Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20061
20073
20081
20101
20121
20131
20145
20161
20179
20181
20191
20203
20213
20221
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting6
Recruiting5
Terminated3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS San Raffaele4
Bristol-Myers Squibb3
European Organisation for Research and Treatment of Cancer - EORTC3
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS3
Novartis Pharmaceuticals3
Astellas Pharma Global Development, Inc.2
Bayer2
Eli Lilly and Company2
Regina Elena Cancer Institute2
Alfredo Berruti1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms45
Carcinoma, Non-Small-Cell Lung2
Melanoma2
Ovarian Neoplasms2
Adenocarcinoma1
Breast Neoplasms1
Disease1
Endometrial Neoplasms1
Esophageal Neoplasms1
Esophageal Squamous Cell Carcinoma1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.